Alzheimer's trial results lend momentum to strategies targeting tau(www.science.org)
3 pointsby lonelyasacloud3 hours ago1 comment
  • lonelyasacloud3 hours ago
    Lowers the protein and achieves 26% slowing of decline but unexpected decreasing cognitive benefits at higher dosage